URL of this page: https://medlineplus.gov/genetics/gene/tcirg1/

TCIRG1 gene

T cell immune regulator 1, ATPase H+ transporting V0 subunit a3
From Genetics Home Reference. Learn more

Normal Function

The TCIRG1 gene provides instructions for making one part, the a3 subunit, of a large protein complex known as a vacuolar H+-ATPase (V-ATPase). V-ATPases are a group of similar complexes that act as pumps to move positively charged hydrogen atoms (protons) across membranes. This movement of protons helps regulate the relative acidity (pH) of cells and their surrounding environment. Tight control of pH is necessary for most biological reactions to proceed properly.

The V-ATPases containing the a3 subunit play an essential role in specialized cells called osteoclasts. These cells break down bone tissue as part of the normal process of bone remodeling, in which old bone is removed and new bone is created to replace it. Bones are constantly being remodeled, and the process is carefully controlled to ensure that bones stay strong and healthy.

On the surface of osteoclasts, V-ATPases are embedded in a specialized, highly folded membrane called the ruffled border. The ruffled border faces the surface of bone, where it helps form a tightly sealed compartment between the osteoclast and the bone surface. V-ATPases pump protons into the compartment, making it very acidic. This acidic environment is necessary to break down bone.

Health Conditions Related to Genetic Changes

Osteopetrosis

More than 60 mutations in the TCIRG1 gene have been identified in people with osteopetrosis. These mutations cause the most severe form of the disorder, autosomal recessive osteopetrosis (ARO).

Many TCIRG1 gene mutations change how the gene's instructions are used to make the a3 subunit of V-ATPase. Other mutations change single protein building blocks (amino acids) in the a3 subunit or lead to the production of an abnormally short version of the subunit. Studies suggest that most of the TCIRG1 gene mutations responsible for osteopetrosis eliminate the function of the a3 subunit.

Without the a3 subunit, V-ATPases cannot pump protons out of osteoclasts. As a result, the compartment between the ruffled border and the bone surface is not acidified, and bone cannot be broken down. When old bone is not broken down as new bone is formed, bones throughout the skeleton become unusually dense. The bones are also structurally abnormal, making them prone to fracture. These problems with bone remodeling underlie the major features of autosomal recessive osteopetrosis.

More About This Health Condition

Severe congenital neutropenia

MedlinePlus Genetics provides information about Severe congenital neutropenia

More About This Health Condition

Other Names for This Gene

  • Atp6i
  • ATP6N1C
  • ATP6V0A3
  • ATPase, H+ transporting, 116kD
  • OC-116
  • OC-116 kDa
  • OC-116kDa
  • OC116
  • OPTB1
  • osteoclastic proton pump 116 kDa subunit
  • specific 116-kDa vacuolar proton pump subunit
  • Stv1
  • T cell immune response cDNA7 protein
  • T-cell immune regulator 1
  • T-cell immune regulator 1, ATPase H+ transporting V0 subunit a3
  • T-cell immune response cDNA 7
  • T-cell immune response cDNA7 protein
  • T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 protein a
  • T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 protein A3
  • T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3
  • TIRC7
  • V-ATPase 116 kDa
  • V-ATPase 116-kDa
  • V-type proton ATPase 116 kDa subunit a
  • V-type proton ATPase 116 kDa subunit a isoform 3
  • vacuolar proton translocating ATPase 116 kDa subunit A
  • Vph1
  • VPP3_HUMAN

Additional Information & Resources

Tests Listed in the Genetic Testing Registry

Scientific Articles on PubMed

Catalog of Genes and Diseases from OMIM

Research Resources

References

  • Frattini A, Orchard PJ, Sobacchi C, Giliani S, Abinun M, Mattsson JP, Keeling DJ, Andersson AK, Wallbrandt P, Zecca L, Notarangelo LD, Vezzoni P, Villa A. Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat Genet. 2000 Jul;25(3):343-6. Citation on PubMed
  • Kornak U, Schulz A, Friedrich W, Uhlhaas S, Kremens B, Voit T, Hasan C, Bode U, Jentsch TJ, Kubisch C. Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis. Hum Mol Genet. 2000 Aug 12;9(13):2059-63. Citation on PubMed
  • Nishi T, Forgac M. The vacuolar (H+)-ATPases--nature's most versatile proton pumps. Nat Rev Mol Cell Biol. 2002 Feb;3(2):94-103. Review. Citation on PubMed
  • Scimeca JC, Quincey D, Parrinello H, Romatet D, Grosgeorge J, Gaudray P, Philip N, Fischer A, Carle GF. Novel mutations in the TCIRG1 gene encoding the a3 subunit of the vacuolar proton pump in patients affected by infantile malignant osteopetrosis. Hum Mutat. 2003 Feb;21(2):151-7. Citation on PubMed
  • Sobacchi C, Frattini A, Orchard P, Porras O, Tezcan I, Andolina M, Babul-Hirji R, Baric I, Canham N, Chitayat D, Dupuis-Girod S, Ellis I, Etzioni A, Fasth A, Fisher A, Gerritsen B, Gulino V, Horwitz E, Klamroth V, Lanino E, Mirolo M, Musio A, Matthijs G, Nonomaya S, Notarangelo LD, Ochs HD, Superti Furga A, Valiaho J, van Hove JL, Vihinen M, Vujic D, Vezzoni P, Villa A. The mutational spectrum of human malignant autosomal recessive osteopetrosis. Hum Mol Genet. 2001 Aug 15;10(17):1767-73. Citation on PubMed
  • Susani L, Pangrazio A, Sobacchi C, Taranta A, Mortier G, Savarirayan R, Villa A, Orchard P, Vezzoni P, Albertini A, Frattini A, Pagani F. TCIRG1-dependent recessive osteopetrosis: mutation analysis, functional identification of the splicing defects, and in vitro rescue by U1 snRNA. Hum Mutat. 2004 Sep;24(3):225-35. Citation on PubMed
From Genetics Home Reference

Genetics Home Reference has merged with MedlinePlus. Genetics Home Reference content now can be found in the "Genetics" section of MedlinePlus. Learn more

The resources on this site should not be used as a substitute for professional medical care or advice. Users with questions about a personal health condition should consult with a qualified healthcare professional.